Donna Roy Grogan insider trades

Open-market stock purchases and sales by Donna Roy Grogan, Director at C4 Therapeutics, Inc, from SEC Form 4 filings since Sep 18, 2019.

Recent trades

DateStockTradeValue
Oct 1, 2026CCCC C4 Therapeutics, IncBought (not open market)$14.5K
Jul 1, 2026CCCC C4 Therapeutics, IncBought (not open market)$14.5K
Jun 24, 2026CCCC C4 Therapeutics, IncBought (not open market)—
Apr 1, 2026CCCC C4 Therapeutics, IncBought (not open market)$14.5K
Jan 2, 2026CCCC C4 Therapeutics, IncBought (not open market)$14.5K

Companies traded

  • CCCC C4 Therapeutics, Inc: other filings, last Oct 1, 2026
  • MNTA Momenta Pharmaceuticals Inc: other filings, last Oct 1, 2020

Get free alerts when Donna Roy Grogan files a new trade →